bioRxiv
Verdict: NotableDesign of full-length agonist and antagonist antibodies for hard targets
Therapeutic antibodies have transformed modern medicine, yet conventional discovery relies on lengthy experimental workflows, offers limited control over how antibodies engage their targets, and struggles to deliver…